KA
TMO icon

Kerrisdale Advisers’s Thermo Fisher Scientific TMO Stock Holding History

Kerrisdale Advisers’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-13,394
Closed -$6.11M – 58
2021
Q1 		$6.11M Sell
13,394
-29,806
-69% -$14.2M 0.47% 38
2020
Q4 		$20.1M Buy
43,200
+39,200
+980% +$18.4M 1.56% 23
2020
Q3 		$1.77M Hold
4,000
– – 0.13% 59
2020
Q2 		$1.45M Buy
+4,000
New +$1.34M 0.16% 55

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Kerrisdale Advisers's TMO Position: Q2 2021 in Review

Kerrisdale Advisers sold out of Thermo Fisher Scientific (TMO) in Q2 2021, closing a stake of 13,394 shares — an estimated $6.11M sold.

Kerrisdale Advisers first reported a position in TMO in Q2 2020 and held it in 4 quarters. The position peaked at $20.1M in Q4 2020. 2,074 funds tracked by Wall St. Rank hold TMO as of Q2 2021.

  • Kerrisdale Advisers reported no remaining Thermo Fisher Scientific position as of Q2 2021 after selling out during the quarter.
  • Kerrisdale Advisers sold 13,394 Thermo Fisher Scientific shares in Q2 2021, an estimated $6.11M.
  • Kerrisdale Advisers first reported a position in Thermo Fisher Scientific in Q2 2020 and held it in 4 quarters.
  • Kerrisdale Advisers's Thermo Fisher Scientific position peaked at $20.1M in Q4 2020.
  • 2,074 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2021.

Based on Kerrisdale Advisers's 13F filing for Q2 2021, filed 16 Aug 2021.